Myeloid clonal hematopoiesis of indeterminate potential in patients with chronic lymphocytic leukemia

•The prevalence of myeloid CHIP in patients with CLL was 12% in untreated and 24% in treated patients (85% with prior chemotherapy exposure).•The presence of ≥2 M-CHIP mutations was associated with survival, even accounting for prior treatment and age. [Display omitted] Clonal hematopoiesis of indet...

Ausführliche Beschreibung